Two studies suggested the diabetes/weight-loss drug may have a beneficial side effect—but more work is needed to confirm this ...

New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce ...

NO doubt you’ve heard the warnings. Drugs come with side effects – often unpleasant, dangerous, in rare cases ...

dementia. In two newly published studies, researchers have found a strong link between GLP-1 receptor agonists, a class of drugs that includes Ozempic, Trulicity, and Victoza, and a significantly ...

Cure should be the goal of therapy for Alzheimer’s dementia, the study, published in the Journal of Alzheimer’s Disease, ...

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may significantly reduce the risk of dementia, particularly in individuals with type 2 ...

The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take ...

Image credit: mbbirdy/Getty Images. A new study investigates the relationship between specific diabetes drugs and dementia. They used data from more than 92,000 people with type 2 diabetes.

The average age of the people in the study was around 65. Watch out for hype about GLP-1s – like Ozempic – and dementia prevention, though, said Diana Thiara, MD, medical director of the ...